Logos Global Management LP
- SEC CIK
- 0001792126
- 最新申報
- 2026/8/14
2023 年第 3 季持倉
持倉截至 2023/9/30，2023/11/14 申報。只含多頭部位，變化是跟 2023 年第 2 季比股數。
- 持股檔數
- 52
- 較 2023 年第 2 季 +2
- 總值
- $7.01 億
- 較 2023 年第 2 季 −$2,300 萬 (−3.2%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| IMVTImmunovant, Inc. | COM | 1,600,000 | $6,142 萬 | 8.8% | −650,000−28.9% | 減碼 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,250,000 | $6,071 萬 | 8.7% | +500,000+28.6% | 加碼 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 3,743,875 | $4,624 萬 | 6.6% | 00.0% | 不變 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,975,000 | $4,047 萬 | 5.8% | +1,725,000+690.0% | 加碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 1,250,000 | $3,683 萬 | 5.3% | −400,000−24.2% | 減碼 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 600,000 | $3,035 萬 | 4.3% | +80,000+15.4% | 加碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 750,000 | $2,853 萬 | 4.1% | +125,000+20.0% | 加碼 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 500,000 | $2,521 萬 | 3.6% | +100,000+25.0% | 加碼 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 200,000 | $2,424 萬 | 3.5% | −100,000−33.3% | 減碼 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 450,000 | $2,336 萬 | 3.3% | −50,000−10.0% | 減碼 | 歷史 |
| ICVXIcosavax, Inc. | COM | 2,765,741 | $2,143 萬 | 3.1% | +600,000+27.7% | 加碼 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 2,180,000 | $1,953 萬 | 2.8% | +400,000+22.5% | 加碼 | 歷史 |
| KRTXKaruna Therapeutics, Inc. | COM | 115,000 | $1,945 萬 | 2.8% | +80,000+228.6% | 加碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 150,000 | $1,688 萬 | 2.4% | −150,000−50.0% | 減碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 1,050,000 | $1,611 萬 | 2.3% | −75,000−6.7% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 450,000 | $1,537 萬 | 2.2% | +175,000+63.6% | 加碼 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 700,000 | $1,528 萬 | 2.2% | +700,000 | 新進 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 1,200,000 | $1,402 萬 | 2.0% | +1,200,000 | 新進 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 300,000 | $1,307 萬 | 1.9% | +300,000 | 新進 | 歷史 |
| ANNXAnnexon, Inc. | COM | 5,300,000 | $1,251 萬 | 1.8% | +1,800,000+51.4% | 加碼 | 歷史 |
| IMTXImmatics N.V. | SHS | 1,050,000 | $1,216 萬 | 1.7% | +550,000+110.0% | 加碼 | 歷史 |
| DSGNDesign Therapeutics, Inc. | COM | 5,032,501 | $1,188 萬 | 1.7% | +2,235,000+79.9% | 加碼 | 歷史 |
| ALLKAllakos Inc. | COM | 4,650,000 | $1,056 萬 | 1.5% | −600,000−11.4% | 減碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 400,000 | $1,055 萬 | 1.5% | +100,000+33.3% | 加碼 | 歷史 |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 400,000 | $917.0 萬 | 1.3% | +400,000 | 新進 | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 900,000 | $866.7 萬 | 1.2% | +900,000 | 新進 | 歷史 |
| VTYXVentyx Biosciences, Inc. | COM | 225,000 | $781.4 萬 | 1.1% | −25,000−10.0% | 減碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 250,000 | $743.5 萬 | 1.1% | +250,000 | 新進 | 歷史 |
| Gracell Biotechnologies Inc38406L103 | SPONSORED ADS | 2,525,000 | $727.2 萬 | 1.0% | +725,000+40.3% | 加碼 | – |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 950,000 | $703.0 萬 | 1.0% | +950,000 | 新進 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 250,000 | $692.0 萬 | 1.0% | +250,000 | 新進 | 歷史 |
| Morphosys AG617760202 | SPONSORED ADS | 950,000 | $638.4 萬 | 0.9% | −250,000−20.8% | 減碼 | – |
| GERNGeron Corp | COM | 2,750,000 | $583.0 萬 | 0.8% | +550,000+25.0% | 加碼 | 歷史 |
| MRUSMerus N.V. | COM | 245,000 | $577.7 萬 | 0.8% | +245,000 | 新進 | 歷史 |
| ALXOAlx Oncology Holdings Inc | COM | 1,000,000 | $480.0 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| ETNB89bio, Inc. | COM | 310,000 | $478.6 萬 | 0.7% | +310,000 | 新進 | 歷史 |
| DCTHDelcath Systems, Inc. | COM NEW | 1,044,444 | $423.0 萬 | 0.6% | −134,343−11.4% | 減碼 | 歷史 |
| ELVNEnliven Therapeutics, Inc. | COM | 307,076 | $419.5 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 544,960 | $406.5 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 125,000 | $368.9 萬 | 0.5% | +125,000 | 新進 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 300,000 | $362.4 萬 | 0.5% | +300,000 | 新進 | 歷史 |
| VERVVerve Therapeutics, Inc. | COM | 215,000 | $285.1 萬 | 0.4% | +215,000 | 新進 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 424,000 | $279.8 萬 | 0.4% | +424,000 | 新進 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 210,000 | $257.3 萬 | 0.4% | +84,285+67.0% | 加碼依 1 比 25 拆股換算 | 歷史 |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 115,000 | $132.3 萬 | 0.2% | +115,000 | 新進 | 歷史 |
| VIGLVigil Neuroscience, Inc. | COM | 188,390 | $101.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| IOBTIO Biotech, Inc. | COM | 493,827 | $69.6 萬 | 0.1% | +493,827 | 新進 | 歷史 |
| IMUXImmunic, Inc. | COM | 421,184 | $61.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CYPHCypherpunk Technologies Inc. | COM NEW | 354,266 | $48.9 萬 | 0.1% | +354,266 | 新進 | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 31,872 | $43.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| LIANYLianBio | SPONSORED ADS | 280,000 | $41.7 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 66,666 | $6,667 | <0.1% | 00.0% | 不變 | – |
選擇權（4 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2023 年第 2 季之後清倉（15 檔）
2023 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 2 季股數 | 2023 年第 2 季市值 | 2023 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| BIIBBiogen Inc. | COM | 100,000 | $2,849 萬 | 3.9% | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 500,000 | $1,581 萬 | 2.2% | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 750,000 | $1,523 萬 | 2.1% | 歷史 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 520,000 | $1,327 萬 | 1.8% | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 250,000 | $1,017 萬 | 1.4% | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 800,000 | $947.2 萬 | 1.3% | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 2,800,000 | $921.2 萬 | 1.3% | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 100,000 | $866.8 萬 | 1.2% | 歷史 |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 650,000 | $776.1 萬 | 1.1% | 歷史 |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 525,000 | $570.1 萬 | 0.8% | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 525,000 | $544.4 萬 | 0.8% | 歷史 |
| KURAKura Oncology, Inc. | COM | 500,000 | $529.0 萬 | 0.7% | 歷史 |
| VIRVir Biotechnology, Inc. | COM | 200,000 | $490.6 萬 | 0.7% | 歷史 |
| TNYATenaya Therapeutics, Inc. | COM | 600,000 | $352.2 萬 | 0.5% | 歷史 |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 1,200,000 | $228.0 萬 | 0.3% | 歷史 |